Repligen Reports Third Quarter 2018 Financial Results

Go back to Repligen Reports Third Quarter 2018 Financial Results

Repligen (RGEN) Tops Q3 EPS by 2c, Revenues Beat; Boosts FY18 EPS/Revenue Guidance

November 1, 2018 7:39 AM EDT

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $49.5 million versus the consensus estimate of $46.74 million.

Tony J. Hunt, President and Chief Executive Officer said, Our third quarter financial performance was highlighted by across the board strength with overall 24% organic revenue... More